Thursday, January 8, 2026
12 C
Delhi
No menu items!

Converge Biotech Announces the Launch of Vergiflu (Favipiravir 200 mg) in India to Treat Mild to Moderate Covid-19

Reading Time: 2 minutes

Arun Kumar Bijjala - Managing Director (Converge Biotech) with VergifluConverge Biotech, a leading healthcare company based at Hyderabad, today announces the launch of generic Favipiravir tablet in India. It will be marketed under the brand name ‘VERGIFLU’ and is indicated for use in mild to moderate COVID-19 patients. Vergiflu is orally administered making it a convenient treatment option.

“We are delighted to announce the launch of Vergiflu for treatment of mild to moderate COVID-19 patients. At a time when cases are witnessing an alarming trend, our accelerated launch is aimed towards offering patients in India a much needed and timely therapy option. This strengthens our portfolio and keeps our commitment of bringing affordable therapy, accessible to patients,” said Managing Director of Converge Biotech Pvt Ltd, Arun Kumar Bijjala.

Favipiravir is an off patent; broad spectrum oral anti-viral drug backed by strong clinical evidence and has been shown to hasten clinical recovery in COVID -19 patients with mild to moderate symptoms. The drug is already approved for novel or re-emerging pandemic influenza virus infection in Japan since 2014, where high recovery rates have been reported with both 7 and 14 days of therapy in both mild and moderate patients. The drug has shorter viral clearance and faster recovery rate and is reported to have a wide therapeutic safety margin for COVID-19 dose.

The mechanism of action of Favipiravir is novel compared to existing influenza antivirals that primarily prevent entry and exit of the virus from cells. The drug has high affinity to RNA virus specific RNA polymerase and gets converted into an active phosphoribosylated form (favipiravir-RTP) in cells thereby inhibiting RNA polymerase activity.

The product is available from today in all major hospitals across the country. It will be sold only on prescription and the company will make sure that the drug is available to the patients.

Converge Biotech also has Prabinex HD (Injection vitamins c 1.5 g), Doxiverge (Inj Doxycycline 100 mg) and Oxihalt (Inj Glutathione 600mg) for hospitalised patients along with immunity boosters, Prabinex 500 mg (Tab Vitamin C 500mg) and Prabinex Z (Tab Vitamin C 500mg with Zinc 20mg); Divify (Vitamin D3 strips) and Tancyvit (Multivitamin).

How useful was this post?

Click on a star to rate it!

Average rating 0 / 5. Vote count: 0

No votes so far! Be the first to rate this post.

Views: 0

Hot this week

The Best Bonus in Zambia: A Comprehensive Guide

If you are looking for the best bonus in...

How Modern Technology Shapes the iGaming Experience

The iGaming industry has evolved...

Gen-Z Entrepreneurs

Introduction: A New Generation Leads the Innovation Wave Gen-Z founders...

DroneTech Adoption Expands Across Agriculture& Logistics in India

Introduction: DroneTech Moves Into Mainstream Use Drone technology in India...

Robotics Adoption Rises Across Indian Manufacturing

Introduction: Automation Becomes a Survival Strategy India’s manufacturing sector entered...

Topics

The Best Bonus in Zambia: A Comprehensive Guide

If you are looking for the best bonus in...

Gen-Z Entrepreneurs

Introduction: A New Generation Leads the Innovation Wave Gen-Z founders...

DroneTech Adoption Expands Across Agriculture& Logistics in India

Introduction: DroneTech Moves Into Mainstream Use Drone technology in India...

Robotics Adoption Rises Across Indian Manufacturing

Introduction: Automation Becomes a Survival Strategy India’s manufacturing sector entered...

Startup Governance Becomes a Funding Requirement

Introduction: Governance Moves to the Center of the Conversation If...

The Future of Indian Workspaces

Introduction: Work Culture Reaches a Turning Point Four years after...

India’s IPO Pipeline 2026

Introduction: A New IPO Cycle Begins After a volatile 2022–2025...
spot_img

Related Articles

Popular Categories

spot_imgspot_img